Biologics development driven by our passion for a better world
KinBio is a rapidly growing biopharmaceutical company focused on the development of generic versions of complex drugs and biosimilars. As a part of a global pharmaceutical group, we focus on promising opportunities in the biologics and biosimilar market. Leveraging our expertise in development, manufacturing and commercialization, we consistently deliver high added value pharmaceuticals to patients in need.
Our approach to developing successful products is strengthened by the application of state of the art technological platforms. We apply our vast experience and creativity in an efficient manner to make advanced therapies more accessible.
KinBio offers a one stop shop for the development, characterization and manufacturing of protein therapeutics and other pharmaceuticals specific to your needs.
Experienced and highly motivated scientists at KinBio’s R&D team are responsible for the development of multiple products, manufacturing technologies and technological solutions.
